Laboratorio Reig Jofré S.A.

https://www.reigjofre.com

REIG JOFRE is a pharmaceutical company born out of a strong belief in making health universally accessible delivering everything from basic care solutions to the most innovative treatments to people around the world. To offer pioneering, high-impact solutions, the company relies on state-of-the-art production technology, ongoing collaboration with innovative companies, researchers, and startups, and sustained investment in R&D. Since 1929, REIG JOFRE has been researching, developing, manufacturing, and marketing pharmaceutical products essential to people’s health across three major areas: Pharmaceutical Technologies (antibiotics and sterile injectable products for hospital use), Specialty Pharmacare (dermatology and osteoarticular therapies) y Consumer Healthcare (ENT and dietary supplements to support health and wellbeing). REIG JOFRE operates four development and production centers in Europe, has in-house teams in Spain, France, Portugal, Belgium, Sweden, the UK, Poland, and the Czech Republic, and maintains a broad network of commercial partners in over 70 countries. With a workforce of more than 1,400 employees, REIG JOFRE closed 2024 with revenue of €339 million (+7% vs. 2023) and an EBITDA of €38 million (+8% vs. 2023). It is listed on the Spanish continuous market under the ticker RJF. *

	Start	1929-01-01 established
	Group	Reig Jofré (Group)
	Industry	pharmaceutical
	Person	Biosca, Ignasi (Reig Jofre 202505 CEO)

	Region	Barcelona
	Country	Spain (España)
	Street	10 Calle Gran Capità
	City	08970 Sant Joan Despí (Barcelona)
	Tel	+34-93-480-67-10
		Address record changed: 2023-12-23

Basic data	Employees	F: 1,001 to 5,000 (2025-05-27)
	Currency	EUR
	Annual sales	339,000,000 (revenue, consolidated (2024) 2024-12-31)

		* Document for »About Section«: Reig Jofre. (5/27/25). "Press Release: Bioglan Opens Cutting-Edge Facility as Swedish Innovation Powers a New Era in Parkinson’s Treatment". Malmö.

		Record changed: 2026-05-02

Picture Berlin Partner Portrait Bio:cap Investival for You 650x200px

More documents for Reig Jofré (Group)

[1] Reig Jofre. (5/27/25). "Press Release: Bioglan Opens Cutting-Edge Facility as Swedish Innovation Powers a New Era in Parkinson’s Treatment". Malmö....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)